Tag: innovative therapies

Myovant Sciences Ltd. Announces Pricing of $75.0 Million Public Offering of Common Shares

BASEL, Switzerland, July 12, 2018 -- Myovant Sciences Ltd. (NYSE: MYOV) ("Myovant"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of...
spot_imgspot_img

Subscribe

Popular articles

Paw.com Unveils Paw Beauty™, Its Debut Grooming Collection

  Paw.com, a popular pet lifestyle brand, has recently launched...

Violife® Teams with Celebrated Chefs

  Promoting the Accessibility of Plant-Based and Dairy-Free Options Upfield leading...
VEGAN WORLD

FREE
VIEW